Introduction

Percutaneous nephrostomy remains a cornerstone interventional radiology procedure for urgent decompression of the obstructed collecting system. This technique provides rapid relief from hydronephrosis, preserves renal function, and establishes access for subsequent antegrade interventions. When performed with ultrasound guidance and meticulous technique, percutaneous nephrostomy achieves technical success in 95–98% of cases while maintaining a favourable safety profile.

The procedure is indicated across a broad spectrum of pathologies, from malignant ureteral obstruction to infected hydronephrosis requiring emergent drainage. Understanding renal vascular anatomy, selecting appropriate access sites, and adhering to strict aseptic protocols are essential for minimizing complications. This article presents an evidence-based protocol designed for radiographers, interventional radiologists, and hospital administration teams seeking to standardize outcomes.

Renal anatomy and pathophysiology

Successful percutaneous nephrostomy requires detailed knowledge of renal vascular and collecting system anatomy. The kidneys are retroperitoneal organs positioned between the T12 and L3 vertebral levels. The renal parenchyma is supplied by segmental end-arteries with minimal collateral circulation, making vascular injury a serious concern.

The posterolateral approach through a lower pole calyx is preferred because it traverses Brodel’s relatively avascular plane, situated between the anterior and posterior segmental arterial distributions. Access above the 12th rib risks pleural transgression and pneumothorax, while medial angulation may injure the renal pelvis or major hilar vessels.

The collecting system comprises the calyces, infundibula, renal pelvis, and ureter. Lower pole calyces typically project lateral and posterior, providing the most direct percutaneous trajectory. The renal pelvis lies medially and should generally be avoided as a primary puncture target due to its proximity to the renal artery and vein.

Pathophysiology of obstruction

Urinary obstruction causes progressive hydronephrosis, elevated intrapelvic pressure, and diminished glomerular filtration. Within 1–2 weeks, irreversible nephron loss may occur if drainage is not established. Infected urine under pressure transforms the collecting system into a closed abscess, accelerating systemic sepsis. Percutaneous nephrostomy interrupts this pathophysiological cascade by decompressing the system and diverting urine externally.

Clinical indications and patient selection

Patient selection for percutaneous nephrostomy balances clinical urgency, anatomical feasibility, and anticipated therapeutic goals. The procedure is broadly categorized into emergent, urgent, and elective indications.

Emergent indications include pyonephrosis, infected hydronephrosis with sepsis, and anuria from bilateral obstruction. In these scenarios, percutaneous nephrostomy is both diagnostic and therapeutic, providing immediate decompression and enabling microbiological sampling.

Urgent indications encompass symptomatic hydronephrosis from ureteral calculi, postoperative urinary leaks, and deteriorating renal function in the setting of malignant obstruction. Elective indications include preoperative access for percutaneous nephrolithotomy, antegrade ureteral stenting, and diversion in preparation for reconstructive urological surgery.

Pre-procedure preparation and imaging

Standard pre-procedure assessment includes a complete blood count, comprehensive metabolic panel, coagulation profile, and type-and-screen. Patients should be NPO for 4–6 hours if moderate sedation is planned. Broad-spectrum antibiotics (cephalosporin or fluoroquinolone) are administered when infection is suspected or confirmed.

Cross-sectional imaging is essential for procedural planning. Non-contrast CT delineates stone burden, identifies the posterior calyx system, and maps adjacent organs. Ultrasound evaluates calyceal dilation in real time and guides the initial puncture. When available, CT-fluoroscopy fusion can enhance targeting accuracy in complex cases such as horseshoe kidneys or transplanted allografts.

The interventional radiologist must review prior imaging to identify vascular variants, retrorenal colon, or pleural extensions that may alter the planned trajectory. Informed consent should explicitly discuss hemorrhage, infection, pneumothorax, and catheter-related complications.

Step-by-step technique

Patient positioning and sterile preparation

The patient is placed in the prone or prone-oblique position with the ipsilateral side elevated 15–20 degrees. This displaces the colon laterally and improves posterior calyx access. The skin is prepared with chlorhexidine or povidone-iodine, and sterile drapes are applied. Local anaesthesia (1% lidocaine) is infiltrated along the planned tract.

Ultrasound-guided puncture

A 3.5–5 MHz curvilinear probe is used to identify the lower pole calyx. The collecting system may be opacified with a small volume of diluted contrast if ultrasound visualization is suboptimal. An 18G trocar needle or 21G Chiba needle with a 0.018-inch mandril wire is advanced under real-time ultrasound guidance into the target calyx. Needle position is confirmed by aspiration of urine or contrast injection under fluoroscopy.

Wire exchange and tract dilation

Once intracaliceal position is confirmed, the 0.018-inch wire is exchanged for a 0.035-inch hydrophilic guidewire (e.g., Glidewire). The wire is advanced into the renal pelvis and, ideally, down the ureter to prevent displacement. A transitional dilator or coaxial system is used to upsize the tract. For standard percutaneous nephrostomy, tract dilation is minimal; larger dilators are reserved for nephrolithotomy access.

Catheter placement and locking

An 8–10F locking pigtail catheter is advanced over the stiff wire into the renal pelvis. The pigtail is formed, and the locking mechanism is engaged to prevent dislodgement. A nephrostogram is performed to confirm intrarenal position and assess the level of obstruction. The catheter is connected to a sterile drainage bag, and a suture or adhesive device secures it to the skin.

Imaging parameters and contrast protocols

Fluoroscopy during percutaneous nephrostomy typically employs pulsed acquisition at 2–3 frames per second to minimize radiation exposure. Digital subtraction angiography is rarely required unless vascular injury is suspected. The nephrostogram is performed with diluted non-ionic iodinated contrast mixed 1:2 with sterile saline.

A total volume of 5–10 mL is hand-injected slowly to opacity the collecting system and define the obstruction level. Rapid or forceful injection risks bacteremia, pyelovenous reflux, and forniceal rupture. If the procedure is performed solely under ultrasound guidance, confirmatory fluoroscopy is still recommended after catheter placement.

For antegrade studies or complex anatomy, CBCT may provide three-dimensional visualization of the collecting system and surrounding vasculature. This is particularly valuable when planning antegrade stent placement or percutaneous nephrolithotomy.

Radiation dose reduction and personnel safety

Percutaneous nephrostomy is predominantly ultrasound-guided, which inherently minimizes fluoroscopic exposure compared with entirely fluoroscopy-dependent procedures. Nevertheless, confirmatory nephrostograms, wire exchanges, and catheter manipulations under fluoroscopy contribute to cumulative dose for both the patient and the interventional team. Adherence to ALARA (As Low As Reasonably Achievable) principles is essential.

Ultrasound guidance for the initial calyceal puncture eliminates the need for pre-procedure fluoroscopic localization, reducing operator and patient dose by 30–50% compared with landmark or fluoroscopy-only techniques. When fluoroscopy is required, pulsed acquisition at the lowest acceptable frame rate (typically 2–3 fps) and tight collimation to the renal fossa limit scatter radiation. Last-image-hold technology should replace repeat acquisitions for documentation.

Personnel protection strategies

All staff within the procedure room must wear lead aprons of at least 0.5 mm lead equivalence. Thyroid shields, leaded eyewear, and ceiling-suspended transparent shields provide additional protection against scatter from the patient’s torso. Dosimetry badges should be worn at collar level outside the lead apron to monitor effective dose to the head and neck, with secondary badges at waist level under the apron to evaluate apron attenuation.

Table-side lead drapes and sterile radiation-attenuating drapes placed over the patient’s abdomen reduce scatter directed toward the operator’s hands and lower extremities. The operator should stand on the image intensifier side of the patient whenever anatomy permits, as scatter intensity falls off rapidly with distance from the X-ray beam entrance site.

SATPro radiation protection solutions

The SATPro range offers integrated radiation protection systems engineered specifically for interventional suites performing drainage procedures. SATPro table-mounted lead drapes and disposable sterile scatter-shield drapes attenuate scatter radiation by up to 75% at the operator position, significantly reducing cumulative occupational exposure for interventional radiologists, radiographers, and nursing staff during lengthy nephrostomy exchanges or antegrade stenting procedures.

SATPro protective eyewear with 0.75 mm lead-equivalent lenses shields the lens of the eye from scatter generated during lateral fluoroscopic runs, while lightweight thyroid collars maintain comfort during extended procedures. For the patient, SATPro collimation aids and beam-filtration accessories optimize image quality at reduced entrance skin dose, supporting compliance with International Commission on Radiological Protection (ICRP) dose reference levels.

Training and culture

Beyond equipment, a robust radiation safety culture requires regular staff training on dose optimization techniques. Radiographers should be empowered to suggest frame-rate reductions, collimation adjustments, and alternative projections that minimize exposure. Peer review of procedural dose reports fosters continuous improvement and identifies outliers who may benefit from additional coaching.

Equipment selection and catheter sizing

Needle selection depends on operator preference and patient anatomy. The 18G trocar needle offers rigidity and rapid access but carries a slightly higher bleeding risk. The 21G Chiba needle is finer and ideal for non-dilated systems, though it requires a coaxial introducer system for wire exchange.

Catheter selection balances drainage efficacy with patient comfort. 8F pigtail catheters suffice for standard decompression, while 10–12F systems are preferred for viscous purulent drainage or anticipated long-term use. Locking mechanisms (e.g., string-lock or hub-lock) prevent inadvertent displacement. Catheters with 10–12 side holes distributed along the intrarenal shaft maximize drainage and reduce occlusion risk.

Accessory equipment includes a 5F Kumpe catheter for selective cannulation, a three-way stopcock for flushing, and a sterile collection bag with an anti-reflux valve. Hydrophilic wires, stiff Amplatz wires, and peel-away sheaths should be available for difficult cases.

Post-procedure care and catheter management

Immediate post-procedure care focuses on hemodynamic monitoring, output assessment, and pain control. Vital signs are recorded every 15 minutes for the first hour. Gross hematuria is common and usually self-limiting within 24–48 hours. Persistent heavy bleeding requires urgent evaluation for arterial injury.

The catheter is left to gravity drainage; capping or clamping is avoided during the initial 24 hours to prevent overdistension and pain. A standard flush protocol involves instilling 10 mL sterile saline every 8–12 hours to maintain patency. Output should be recorded daily, with sudden reductions prompting evaluation for kinking, dislodgement, or encrustation.

Patient education covers catheter care, signs of infection (fever, purulent output, worsening pain), and activity restrictions. Showering is permitted with a waterproof dressing; soaking or swimming is contraindicated until tract maturation (typically 2–3 weeks).

Complications and troubleshooting

Complications of percutaneous nephrostomy are categorized as minor (self-limiting) or major (requiring intervention). Minor complications include transient hematuria, local pain, and low-grade fever. Major complications occur in 5–10% of cases and demand prompt recognition.

Sepsis is the most feared complication, particularly in pyonephrosis. It typically manifests within 2–4 hours of the procedure with fever, tachycardia, and hypotension. Management includes aggressive fluid resuscitation, broad-spectrum antibiotics, and vasopressor support if needed. Prophylactic antibiotics reduce but do not eliminate this risk.

Pneumothorax or hemothorax results from supracostal puncture above the 12th rib. Clinical suspicion should be high in patients with post-procedural dyspnea or desaturation. A chest X-ray confirms the diagnosis; small pneumothoraces may be observed, while larger collections require chest tube drainage.

Catheter dislodgement occurs in 10–15% of cases, particularly in confused or mobile patients. If the tract is mature (>2 weeks), replacement over a guidewire is usually straightforward. For fresh tracts, repeat imaging-guided access may be necessary.

Follow-up protocol and catheter removal

Routine follow-up includes a tube-check nephrostogram at 1–2 weeks to confirm catheter position, assess for kinking, and evaluate obstruction resolution. Long-term catheters require exchange every 4–6 weeks to prevent encrustation and biofilm formation.

Removal criteria include resolution of the underlying obstruction (confirmed by antegrade study or retrograde pyelography), adequate antegrade urine flow without significant leak, and clinical stability. The catheter is clamped for a 24–48 hour trial; if the patient remains afebrile with stable renal function and no flank pain, removal is performed under aseptic conditions.

For patients with irreversible malignant obstruction, the nephrostomy may remain in situ indefinitely or be converted to an internal-external stent. In such cases, palliative care coordination and quality-of-life assessments are essential components of longitudinal management.

Conclusion

Percutaneous nephrostomy is an indispensable skill in the interventional radiology armamentarium, offering rapid, effective decompression of the obstructed urinary tract. Success depends on meticulous attention to anatomical landmarks, rigorous aseptic technique, and individualized equipment selection. The posterolateral lower-pole approach via Brodel’s plane minimizes vascular and pleural complications.

Radiologists must remain vigilant for post-procedural sepsis, hemorrhage, and catheter malfunction. Standardized flush protocols, timely tube-check imaging, and clear patient education reduce long-term morbidity. By integrating evidence-based protocols with modern imaging guidance, departments can achieve technical success rates exceeding 95% while preserving renal function and improving patient outcomes.

For hospital administration, investing in streamlined consumable management and staff training programmes yields measurable improvements in throughput and complication rates. Explore how SATMED Health supports your interventional radiology service line.

References